Search

Search Constraints

You searched for: Author/Creator Brander, Danielle M.

Search Results

2. DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study. Issue 5 (7th March 2023)

3. Effects of high-intensity interval training on health-related quality of life in chronic lymphocytic leukemia: A pilot study. Issue 1 (January 2023)

4. Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study. (24th September 2020)

5. Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial. Issue 11 (26th September 2018)

6. Perifosine treatment in chronic lymphocytic leukemia: results of a phase II clinical trial and in vitro studies. Issue 5 (May 2014)

8. Quality Of Life Changes Following High-intensity Interval Training In Older Adults With Chronic Lymphocytic Leukemia: 607. (September 2022)

10. SET alpha and SET beta mRNA isoforms in chronic lymphocytic leukaemia. (15th November 2018)